Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Journal of Neuropathology and Experimental Neurology
|
August 20, 2016
Clinical, Imaging, Histopathological and Molecular Characterization of Anaplastic Ganglioglioma
Marc Zanello, Mélanie Pages, Arnault Tauziède-Espariat, et al.
Nature Medicine
|
April 26, 2022
Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial
Olivier Mir, Marie Ferrua, Aude Fourcade, et al.
Cancer Medicine
|
November 19, 2018
Ewing's Sarcoma of the Head and Neck: Margins are not just for surgeons
Jebrane Bouaoud, Stephane Temam, Nathalie Cozic, et al.
Cancer Research
|
January 1, 2016
Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer
Noël J-M Raynal, Justin T Lee, Youjun Wang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 22, 2022
Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials
Capucine Baldini, Nadia Younan, Eduardo Castanon Alvarez, et al.
The Lancet. Oncology
|
October 19, 2016
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
Olivier Mir, Thomas Brodowicz, Antoine Italiano, et al.
BMC Cancer
|
August 27, 2017
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study)
Stefano Kim, Marine Jary, Thierry André, et al.
The Lancet. Oncology
|
July 24, 2019
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial
Silvia Stacchiotti, Stefano Ferrari, Andres Redondo, et al.
The Lancet. Oncology
|
December 23, 2018
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial
Javier Martin-Broto, Silvia Stacchiotti, Antonio Lopez-Pousa, et al.
Neuro-Oncology
|
October 21, 2021
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
Matthias Preusser, Antonio Silvani, Emilie Le Rhun, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Journal of Neuropathology and Experimental Neurology
|
August 20, 2016
Clinical, Imaging, Histopathological and Molecular Characterization of Anaplastic Ganglioglioma
Marc Zanello, Mélanie Pages, Arnault Tauziède-Espariat, et al.
Nature Medicine
|
April 26, 2022
Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial
Olivier Mir, Marie Ferrua, Aude Fourcade, et al.
Cancer Medicine
|
November 19, 2018
Ewing's Sarcoma of the Head and Neck: Margins are not just for surgeons
Jebrane Bouaoud, Stephane Temam, Nathalie Cozic, et al.
Cancer Research
|
January 1, 2016
Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer
Noël J-M Raynal, Justin T Lee, Youjun Wang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 22, 2022
Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials
Capucine Baldini, Nadia Younan, Eduardo Castanon Alvarez, et al.
The Lancet. Oncology
|
October 19, 2016
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
Olivier Mir, Thomas Brodowicz, Antoine Italiano, et al.
BMC Cancer
|
August 27, 2017
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study)
Stefano Kim, Marine Jary, Thierry André, et al.
The Lancet. Oncology
|
July 24, 2019
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial
Silvia Stacchiotti, Stefano Ferrari, Andres Redondo, et al.
The Lancet. Oncology
|
December 23, 2018
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial
Javier Martin-Broto, Silvia Stacchiotti, Antonio Lopez-Pousa, et al.
Neuro-Oncology
|
October 21, 2021
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
Matthias Preusser, Antonio Silvani, Emilie Le Rhun, et al.
Page
of 4